Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-03-10
2000-12-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514159, 514162, 514165, 5142265, 514356, 514365, 514375, 514404, 514419, 514420, 514423, 514428, 514429, 514448, 514567, 514569, A61K 3160, A61K 31615, A61K 3154, A61K 31425, A61K 3142, A61K 31415, A61K 3140, A61K 3138, A61K 31195, A61K 3119
Patent
active
061600180
ABSTRACT:
A method of preventing or delaying the onset of symptoms of Alzheimer's Disease includes the step of administering to a patient in need of such treatment a composition having an effective Alzheimer's Disease prophylactic amount of an enantiomerically stable R-NSAID or a pharmaceutically acceptable salt thereof, the composition being substantially free of the S-enantiomer of the selected R-NSAID.
REFERENCES:
patent: 3755427 (1973-08-01), Adams et al.
patent: 4983765 (1991-01-01), Lukas et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5200198 (1993-04-01), Geisslinger et al.
patent: 5206029 (1993-04-01), Brune et al.
patent: 5331000 (1994-07-01), Young et al.
patent: 5382591 (1995-01-01), Barberich et al.
patent: 5560924 (1996-10-01), Wunderlich et al.
W.J. Wechter: "Drug Chirality: On the Mechanism of R-Aryl Propionic Acid Class NSAIDS. Epimerization in Humans and the Clinical Implications for the Use of Racemates." J. Clin. Pharmacol., vol. 34, No. 11, 1994, pp. 1036-1042.
W.J. Wechter: "RAC-Flurbiprofen is More Ulcerogenic than its (S)-Enantiomer." Chirality, vol. 5, No. 7, 1993 pp. 492-494.
Hixson et al., Cancer Epidemiol., Biomarkers Prev. (1994) 3(5), 433-8 Abstract Only.
Menzel--Soglowek et al., "Metabolic Chiral Inversion of 2-Arylpropionates in Different Tumor Cell Lines", Varabiality in Response to Anti-Rheumatic Drugs/Agnets and Action Supplements, vol. 44, 1993, pp. 23-29.
Heath, et al., "Nonsteroidal Antiinflammatory Drugs and Human Cancer," Cancer, 1994; 74:2885-8.
Waterhouse, et al., "Aspirin, NSAIDS, and Risk Reduction of Colorectal Cancer", Arch Intern Med. vol. 154, Feb. 28, 1994; pp. 366-368.
Lipkin, "Biomakers of Increased Susceptibility to Gastrointestinal Cancer: New Application to Studies of Cancer Prevention in Human Subjects", Cancer Research 48, Jan. 15, 1988; pp. 235-245.
Jamali, "Pharmacokinetics of Enantiomers of Chiral Non-Steroidal Anti-inFlammatory Drugs", Eur. J Drug Metab Pharmacokin, 1988; vol. 13, No. 1, pp. 1-9.
Moertel, et al., "Levamisole and Fluroouracil for Adjuvant Therapy of Resected Colon Carcinoma", New England Journal of Medicine, 1990; 322:352-8.
Marnett, "Aspirin and the Potential Role of Prostaglandins in Colon Cancer,"Cancer Research, 1992; 52:5575-89.
Welberg et al., "Proliferation Rate of Colonic Mucosa in Normal Subjects and Patients with Colonic Neoplasms: A Refined Immunohistochemical Method", J Clin Pathol, 1990: 43-453-456.
Thun et al., "Aspirin Use and Reduced Risk of Fatal Colon Cancer," N Engl J Med 1991: 325: 1593-6.
Peleg, et al., "Aspirin and Nonsteroidal Antiflammatory Drug Use and the Risk of Subsequent Colorectal Cancer" Arch Intern Med. 1994; 154:394-9.
Gridley, et al., "Incidence of Cancer Among Patients with Rheumatoid Arthritis", J Natl Cancer Inst. 1993; 85:307-311.
Labayle, et al., "Sulindac Causes Regression of Rectal Polyps in Famlial Adenomatous Polyposis", Gastoenterology, 1991; 101:635-639.
Rigau, et al., "Effects of Long-Term Sulindac Therapy on Colonic Polyposis", Annals of Internal Medicine, 1991 115:952-954.
Giardiello, et al., "Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis" N Eng J Med, 1993; 328:1313-6.
Pollard, et al., "Effect of Indomethacin on Intestinal Tumors Induced in Rats by the Acetate Derivative of Dimethylnitrosamine"; Science, Oct. 30, 1981; vol. 214, pp. 558-559.
Reddy, et al., "Inhibitory Effect on Aspirin on Azoxymethane-Induced Colon Carcinogenesis in F344 Rats", Carcinogenesis, 1993; vol. 14, No. 8, pp. 1493-1497.
Gibaldi et al., Pharmacokinetics, 1982, Chapter 1, pp. 1-5.
Mauch, Thomas H. II; "Ibuprofen Use Cuts Alzheimer's Risk, Study Says"; Los Angeles Times; Mar. 10, 1997; pp. A1 and A20.
McCracken John D.
Wechter William J.
Goldberg Jerome D.
Loma Linda University Medical Center
LandOfFree
Prophylactic composition and method for alzheimer's Disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic composition and method for alzheimer's Disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic composition and method for alzheimer's Disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218317